Nicole Lambert - 27 Aug 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Signature: By: Nathan A. Smith For: Nicole Lambert
Issuer symbol: MYGN
Transactions as of: 27 Aug 2021
Net transactions value: -$32,602
Form type: 4
Filing time: 30 Aug 2021, 16:11:46 UTC
Previous filing: 26 Aug 2021
Next filing: 23 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYGN	Common Stock	Sale	$32,602	-945	-0.74%	$34.50	127,051	27 Aug 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Remarks:

Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.